57.100
|
NHSN Registration Form
|
No change
|
No changes
|
N/A
|
57.101
|
Facility Contact
Information
|
No change
|
Update form to
include section for the new Antimicrobial Use and Resistance
Component.
|
The
form was updated to include applicable sections for the new
Antimicrobial Use and Resistance Component.
This change does not
affect the estimated burden of this form.
|
57.103
|
Patient Safety
Component-Annual Hospital Survey
|
No change
|
Revision
of questions within the Facility Microbiology Laboratory
Practices section.
Addition
of new section for Infection Control Practices.
Addition of new
section for Antibiotic Stewardship Practices.
|
The
Facility Microbiology Laboratory Practices section of the survey
was reviewed by internal laboratory experts and it was
determined that some questions were no longer needed as the
majority of laboratories are following similar practices to
adhere to industry guidelines. Response options were also added
to be inclusive of all laboratory types used by healthcare
facilities. A few questions were added to obtain information
regarding activities to prevent furthering of antimicrobial
resistance within the individual healthcare facility.
Questions
about infection control practices have been added to the survey
for the purpose of gaining a better understanding of current
practices and to identify areas to target prevention efforts
among facilities that have reported a multidrug-resistant
organism. The information collected will inform future efforts
to improve facility implementation of recommended prevention
measures to control spread of multidrug-resistant organisms.
Questions
about antibiotic stewardship have been added to the survey for
the purpose of gaining a better understanding of current efforts
to improve antibiotic use in hospitals and to assess the quality
of hospital antibiotic stewardship programs. The information
collected will inform efforts to improve facility implementation
of best practices to improve antibiotic stewardship programs and
antibiotic use in hospitals.
These changes result in
an increase of 2,000 burden hours for this form.
|
57.105
|
Group Contact Information
|
No change
|
Decrease the
total number of respondents from 6,000 to 1,000.
|
After
reviewing the use of this form, it was determined that there are
far fewer respondents using this form than originally estimated;
therefore, the total number of respondents has been decreased to
1,000 per year.
This
change results in a decrease of 417 burden hours.
|
57.106
|
Patient Safety Monthly
Reporting Plan
|
No change
|
Remove
Patient Vaccination section of the reporting plan.
|
Due
to low use of the Patient Vaccination Module, it will be removed
from NHSN and therefore removed from the Monthly Reporting Plan.
Additionally,
the form’s estimated time to completion was assessed and
determined to be less than originally projected. The removal of
the Patent Vaccination Module from the form along with the
reduced time to completion decreases the total burden of this
form by 24,000 burden hours.
|
57.108
|
Primary Bloodstream
Infection (BSI)
|
No change
|
Revision
of susceptibility
options for
Cefepime.
Criteria
clarification for neutropenia.
Increase number of
responses from 36 to 44.
|
Recently
CLSI has updated the susceptibility options for Cefepime to
replace Intermediate (I) with Susceptible-dose dependent (S-DD)
for three organisms: Escherichia coli, Enterobacter, and
Klebsiella. However, because not all laboratories will implement
this change at the same time, the susceptibility options for
Cefepime for those three organisms will include both I and S-DD
on all NHSN event forms.
Clarification
was added to the form for the underlying condition of
neutropenia to assist users in making this determination.
In
2015, CMS will be requiring all acute care facilities
participating in the IQR Program to report BSIs from medical,
surgical, and medical/surgical wards within their facilities.
Therefore, the estimated number of times this form will be
completed per facility has been increased from 36 times to 44
times per year.
Additionally,
the form’s estimated time to completion was assessed and
determined to be less than originally projected. These combined
changes result in an increase of 16,800 burden hours for this
form.
|
57.111
|
Pneumonia (PNEU)
|
No change
|
A
number of revisions were made related to modifications of the
PNEU/VAP protocol and reflect simplifications and clarifications
to more accurately reference laboratory testing methodology.
Revision of
susceptibility
options for
Cefepime.
|
As
consistent with all other HAI infection definition
revisions, non-culture laboratory testing results used to meet
the PNEU definition are now group together as one selection and
referred to as Positive
non-culture diagnostic test of respiratory secretions or tissue.
For clarification purposes, delineation between histopathologic
exam test results and culture test results was provided. To that
end Positive
quantitative culture of lung parenchyma is
no longer grouped within the former selection Histopathologic
exam w/ abscess formation, positive quantitative culture of lung
parenchyma, or lung parenchyma invasion by fungal hyphae.
It is now a separate selection. Pneumocystis
carinii was
deleted from the selection: Fungi
or Pneumocystis carinii from LRT specimen
as this reflects a change to the PNEU/VAP protocol whereby
this is now an excluded pathogen for meeting the PNEU
definition.
Recently
CLSI has updated the susceptibility options for Cefepime to
replace Intermediate (I) with Susceptible-dose dependent (S-DD)
for three organisms: Escherichia coli, Enterobacter, and
Klebsiella. However, because not all laboratories will implement
this change at the same time, the susceptibility options for
Cefepime for those three organisms will include both I and S-DD
on all NHSN event forms.
These
changes result in an increase of 7,200 burden hours for this
form.
|
57.112
|
Ventilator-Associated
Event
|
No change
|
Possible
VAP and Probable VAP (third tier of VAE definition algorithm)
were consolidated to create one specific event: PVAP.
Revision of
susceptibility
options for
Cefepime.
|
Possible
VAP and Probable VAP (third tier of VAE definition algorithm)
were consolidated to create one specific event: PVAP. Facilities
have different approaches to processing and reporting Gram stain
and culture data. Having two separate specific events within the
tier (possible and probable) made it difficult to have an
objective definition. Combining the two specific events into one
specific event will simplify the VAE definition algorithm
and is additionally consistent with how analysis would likely be
done (combining possible VAP and Probable VAP to arrive at a
third tier rate).
Recently
CLSI has updated the susceptibility options for Cefepime to
replace Intermediate (I) with Susceptible-dose dependent (S-DD)
for three organisms: Escherichia coli, Enterobacter, and
Klebsiella. However, because not all laboratories will implement
this change at the same time, the susceptibility options for
Cefepime for those three organisms will include both I and S-DD
on all NHSN event forms.
These
changes result in an increase of
43,200 burden hours for
this form.
|
57.114
|
Urinary Tract Infection
(UTI)
|
No change
|
Addition
of new fields.
Addition
of the neutropenia criteria.
Removal
of dysuria from criteria for children less than 1 year old.
Revision
of specific event type from OUTI to USI.
Revision
of susceptibility
options for
Cefepime.
Estimated number
of responses per respondent was increased from 27 to 40.
|
These
fields (purulence around catheter and acute pain, swelling or
tenderness of the epididymis, testes and prostate) will provide
greater sensitivity in identifying catheter-associated UTIs that
may not have been identified with previous CAUTI definitions.
The
addition of the neutropenia criteria will allow us to be more
specific in identifying UTIs. Immunocompromised patients may
not be able to produce WBCs in response to infection and the
addition of this information allows us to analyze data more
appropriately.
Dysuria
was removed based on input from our pediatrician on staff.
Patients under 1 year of age are very unlikely to express
dysuria so it is not useful for diagnosing UTI in that
population.
OUTI
was changed to USI to clarify that it did not involve a urine
culture and should be considered separately from OUTI. It also
allows for more clear delineation of infections of the urinary
system that occur as a result of surgical procedures.
Recently
CLSI has updated the susceptibility options for Cefepime to
replace Intermediate (I) with Susceptible-dose dependent (S-DD)
for three organisms: Escherichia coli, Enterobacter, and
Klebsiella. However, because not all laboratories will implement
this change at the same time, the susceptibility options for
Cefepime for those three organisms will include both I and S-DD
on all NHSN event forms.
In
2015, CMS will be requiring all acute care facilities
participating in the IQR Program to report UTIs from medical,
surgical, and medical/surgical wards within their facilities.
Therefore, the estimated number of times this form will be
completed per facility has been increased from 27 times to 40
times per year.
These
changes result in an increase of 41,700 burden hours for this
form.
|
57.116
|
Denominators for Neonatal
Intensive Care Unit (NICU)
|
No change
|
No changes
|
N/A
|
57.117
|
Denominators for Specialty
Care Area (SCA)/Oncology (ONC)
|
No change
|
Add field to
capture episodes of mechanical ventilation.
|
Episodes
of Mechanical Ventilation (EMV) was added as an optional
denominator. Decreasing the number of ventilator days is an
intervention aimed at reducing ventilator related event rates.
However, if the ventilator denominator is decreased it is
possible that the rate will not improve and could possibly
increase. The introduction of EMV as a denominator is being
introduced as an alternative means of evaluating VAE rates.
This change does not
affect the estimated burden of this form.
|
57.118
|
Denominators for Intensive
Care Unit (ICU)/Other Locations (Not NICU or SCA)
|
No change
|
Add field to
capture episodes of mechanical ventilation.
|
Episodes
of Mechanical Ventilation (EMV) was added as an optional
denominator. Decreasing the number of ventilator days is an
intervention aimed at reducing ventilator related event rates.
However, if the ventilator denominator is decreased it is
possible that the rate will not improve and could possibly
increase. The introduction of EMV as a denominator is being
introduced as an alternative means of evaluating VAE rates.
This change does not
affect the estimated burden of this form.
|
57.120
|
Surgical Site Infection
(SSI)
|
No change
|
Add
question to assess whether infection was present at the time of
surgery (PATOS).
Remove
question to identify whether the SSI was detected using the NHSN
ICD Code-based Admit and Readmit SSI Surveillance Toolkit.
Revision
of susceptibility
options for
Cefepime.
Revision of
criteria for signs and symptoms of SSI.
|
Adding
this question will allow NHSN to do analysis based on SSIs that
occur when there was an infection present at the time of
the surgery.
This
question was removed from the form as CDC DHQP leadership felt
that this feed was too complicated for users to complete.
Recently
CLSI has updated the susceptibility options for Cefepime to
replace Intermediate (I) with Susceptible-dose dependent (S-DD)
for three organisms: Escherichia coli, Enterobacter, and
Klebsiella. However, because not all laboratories will implement
this change at the same time, the susceptibility options for
Cefepime for those three organisms will include both I and S-DD
on all NHSN event forms.
In
order to be consistent throughout NHSN definitions, SSI signs
and symptoms criteria were amended.
These
changes result in a net increase of 21,600 burden hours for this
form.
|
57.121
|
Denominator for Procedure
|
No change
|
Add question to
assess whether the total or partial knee/hip revision was
associated with prior infection at the index joint.
|
This
question was based on the decisions/discussion of the SSI
Healthcare Infection Control Practices Advisory Committee
(HICPAC) workgroup. These revisions will have a much higher SSI
rate and adding this field will enable better future risk
adjusted data analysis.
This
change does not affect the estimated burden of this form.
|
57.123
|
Antimicrobial Use and
Resistance (AUR)-Microbiology Data Electronic Upload
Specification Tables
|
No change
|
No changes
|
N/A
|
57.124
|
Antimicrobial Use and
Resistance (AUR)-Pharmacy Data Electronic Upload Specification
Tables
|
No change
|
No changes
|
N/A
|
57.125
|
Central Line Insertion
Practices Adherence Monitoring
|
No change
|
No changes
|
N/A
|
57.126
|
MDRO or CDI Infection Form
|
No change
|
Revision
of criteria for signs and symptoms and laboratory or diagnostic
testing of MDRO or CDI infection event.
Add
CRE-Enterobacter
as a specific organism type.
Revision of
susceptibility
options for
Cefepime.
|
In
order to be consistent and remove duplication throughout NHSN
definitions, MDRO or CDI signs and symptoms and laboratory or
diagnostic criteria were amended.
CRE-Enterobacter
added as an option for specific organism type to accommodate an
additional organism and definition change in the MDRO protocols
for LabID Event and Infection Surveillance reporting.
Recently
CLSI has updated the susceptibility options for Cefepime to
replace Intermediate (I) with Susceptible-dose dependent (S-DD)
for three organisms: Escherichia coli, Enterobacter, and
Klebsiella. Therefore the susceptibility options for Cefepime
for those three organisms should be changed from S, I, R, N to
S, S-DD, R, N on all NHSN event forms.
This
change results in an increase of 7,200 burden hours for this
form.
|
57.127
|
MDRO and CDI Prevention
Process and Outcome Measures Monthly Monitoring
|
No change
|
Add
question to obtain denominator counts for total facility
excluding units with unique CMS Certification Numbers (CCNs).
Add
CRE-Enterobacter
as a specific organism type.
|
FacWideIN
reporting for acute care will include locations with the same
CMS Certification Number (CCN) only. Unique CCN’s will be
removed from FacWideIN counts. This change is in alignment with
current and future CMS reporting rules for participating
facilities.
CRE-Enterobacter
added as an option for specific organism type to accommodate an
additional organism and definition change in the MDRO protocols
for LabID Event and Infection Surveillance reporting.
These changes result in
the addition of 7,200 burden hours to this form.
|
57.128
|
Laboratory-identified MDRO
or CDI Event
|
No change
|
Add
CRE-Enterobacter
as a specific organism type.
Add
new question to determine last physical overnight location of
patient immediately prior to arriving into facility.
Add new question
to determine whether patient has been discharged from another
facility in the past 4 weeks.
|
CRE-Enterobacter
added as a specific organism type to accommodate an additional
organism and definition change in the MDRO protocols for LabID
Event and Infection Surveillance reporting.
Last
physical overnight location of patient immediately prior to
arriving into facility (applies to specimen collected in
outpatient setting or <4 days after inpatient admission was
added to enable continuum of care and compliment community onset
data collected by Emerging Infections Program by allowing users
to track referral sources.
Has
patient been discharged from another facility in the past 4
weeks was added to enable continuum of care and enable
facilities to track time spent in other healthcare facilities.
These
changes do not affect the estimated burden of this form.
|
57.130
|
Vaccination Monthly
Monitoring Form-Summary Method
|
No change
|
This form will
be removed from the package as the Patient Vaccination Module
will be removed from NHSN.
|
This
form will be removed from the package as the Patient Vaccination
Module will be removed from NHSN.
Removing
this form results in decreasing the total package burden by 7,000
burden hours.
|
57.131
|
Vaccination Monthly
Monitoring Form-Patient-Level Method
|
No change
|
This form will
be removed from the package as the Patient Vaccination Module
will be removed from NHSN.
|
This
form will be removed from the package as the Patient Vaccination
Module will be removed from NHSN.
Removing
this form results in decreasing the total package burden by 1,000
burden hours.
|
57.133
|
Patient Vaccination
|
No change
|
This form will
be removed from the package as the Patient Vaccination Module
will be removed from NHSN.
|
This
form will be removed from the package as the Patient Vaccination
Module will be removed from NHSN.
Removing
this form results in decreasing the total package burden by 4,167
burden hours.
|
57.137
|
Long-Term Care Facility
Component – Annual Facility Survey
|
No change
|
Addition
of new section for Infection Control Practices.
Addition of new
section for Antibiotic Stewardship Practices.
|
Questions
about infection control practices have been added to the survey
for the purpose of gaining a better understanding of current
practices and to identify areas to target prevention efforts
among facilities that have reported a multidrug-resistant
organism. The information collected will inform future efforts
to improve facility implementation of recommended prevention
measures to control spread of multidrug-resistant organisms.
Questions
about antibiotic stewardship have been added to the survey for
the purpose of gaining a better understanding of current efforts
to improve antibiotic use in hospitals and to assess the quality
of hospital antibiotic stewardship programs. The information
collected will inform efforts to improve facility implementation
of best practices to improve antibiotic stewardship programs and
antibiotic use in hospitals.
These changes result in
an increase of 63 burden hours for this form.
|
57.138
|
Laboratory-identified MDRO
or CDI Event for LTCF
|
No change
|
Add
CRE-Enterobacter
as a specific organism type.
|
CRE-Enterobacter
added as a specific organism type to accommodate an additional
organism and definition change in the MDRO protocols for LabID
Event and Infection Surveillance reporting.
This change does not
affect the estimated burden of this form.
|
57.139
|
MDRO and CDI Prevention
Process Measures Monthly Monitoring for LTCF
|
No change
|
Add
CRE-Enterobacter
as a specific organism type.
|
CRE-Enterobacter
added as a specific organism type to accommodate an additional
organism and definition change in the MDRO protocols for LabID
Event and Infection Surveillance reporting.
This change does not
affect the estimated burden of this form.
|
57.140
|
Urinary Tract Infection
(UTI) for LTCF
|
No change
|
Revision
of susceptibility
options for
Cefepime.
Average time to
complete form was increased to 30 minutes.
|
Recently
CLSI has updated the susceptibility options for Cefepime to
replace Intermediate (I) with Susceptible-dose dependent (S-DD)
for three organisms: Escherichia coli, Enterobacter, and
Klebsiella. Therefore the susceptibility options for Cefepime
for those three organisms should be changed from S, I, R, N to
S, S-DD, R, N on all NHSN event forms.
After
reevaluating the form, it was determined that the average time
to complete the form should be increased from 27 minutes to 30
minutes per response.
These
changes result in an increase of 113 burden hours for this form.
|
57.141
|
Monthly Reporting Plan for
LTCF
|
No change
|
No changes
|
N/A
|
57.142
|
Denominators for LTCF
Locations
|
No change
|
Addition
of a question: “New antibiotic starts for UTI indication.”
Addition of a
question: “Number of admissions on C. difficile
treatment.”
|
This
column is being added to enable nursing home providers to
capture antibiotic starts for UTI indications for all residents
in the facility on a monthly basis. Facilities can track these
new antibiotic starts on a daily basis or provide a total number
at the end of each month. This summary measure will provide
additional context for the interpretation of their UTI event
data and may help identify opportunities for quality improvement
when reported UTI surveillance events are much lower than
clinically treated UTI events.
This
column is being added to enable nursing home providers to
capture residents receiving antibiotic treatment for C.difficile
infection at the time of admission to their facility on a
monthly basis. A growing body of evidence shows that a
healthcare facility’s C.difficile infection rates can be
strongly impacted by the importation of C.difficile from people
actively or recently infected at the time of admission. By
collecting data on the prevalence of C.difficile treatment on
admission, facilities will have a proxy measure of this
importation factor which can be used to interpret their
C.difficile infection rates.
These changes result in
an increase of 750 burden hours for this form.
|
57.143
|
Prevention Process
Measures Monthly Monitoring for LTCF
|
No change
|
No changes
|
N/A
|
57.150
|
Patient Safety Component-
Annual Facility Survey for LTAC
|
No change
|
Addition
of a new question to obtain number of admissions of patients
with certain conditions.
Revision
of questions within the Facility Microbiology Laboratory
Practices section.
Addition
of new section for Infection Control Practices.
Addition of new
section for Antibiotic Stewardship Practices.
|
A
new question was added to the survey to obtain the number of
admissions of patients with certain conditions. These data will
assist in providing accurate risk adjustment of LTAC facility
metrics.
The
Facility Microbiology Laboratory Practices section of the survey
was reviewed by internal laboratory experts and it was
determined that some questions were no longer needed as the
majority of laboratories are following similar practices to
adhere to industry guidelines. Response options were also added
to be inclusive of all laboratory types used by healthcare
facilities. A few questions were added to obtain information
regarding activities to prevent furthering of antimicrobial
resistance within the individual healthcare facility.
Questions
about infection control practices have been added to the survey
for the purpose of gaining a better understanding of current
practices and to identify areas to target prevention efforts
among facilities that have reported a multidrug-resistant
organism. The information collected will inform future efforts
to improve facility implementation of recommended prevention
measures to control spread of multidrug-resistant organisms.
Questions
about antibiotic stewardship have been added to the survey for
the purpose of gaining a better understanding of current efforts
to improve antibiotic use in hospitals and to assess the quality
of hospital antibiotic stewardship programs. The information
collected will inform efforts to improve facility implementation
of best practices to improve antibiotic stewardship programs and
antibiotic use in hospitals.
These changes result in
an increase of 133 burden hours for this form.
|
57.151
|
Patient Safety
Component-Annual Facility Survey for IRF
|
No change
|
Revision
of questions within the Facility Microbiology Laboratory
Practices section.
Addition
of new section for Infection Control Practices.
Addition of new
section for Antibiotic Stewardship Practices.
|
The
Facility Microbiology Laboratory Practices section of the survey
was reviewed by internal laboratory experts and it was
determined that some questions were no longer needed as the
majority of laboratories are following similar practices to
adhere to industry guidelines. Response options were also added
to be inclusive of all laboratory types used by healthcare
facilities. A few questions were added to obtain information
regarding activities to prevent furthering of antimicrobial
resistance within the individual healthcare facility.
Questions
about infection control practices have been added to the survey
for the purpose of gaining a better understanding of current
practices and to identify areas to target prevention efforts
among facilities that have reported a multidrug-resistant
organism. The information collected will inform future efforts
to improve facility implementation of recommended prevention
measures to control spread of multidrug-resistant organisms.
Questions
about antibiotic stewardship have been added to the survey for
the purpose of gaining a better understanding of current efforts
to improve antibiotic use in hospitals and to assess the quality
of hospital antibiotic stewardship programs. The information
collected will inform efforts to improve facility implementation
of best practices to improve antibiotic stewardship programs and
antibiotic use in hospitals.
These
changes result in an increase of 417 burden hours for this form.
|
57.154
|
Antimicrobial
Use & Resistance Component - Monthly Reporting Plan
|
N/A. This is a new form
|
A new form is being added
as part of the new NHSN Antimicrobial Use and Resistance
Component.
|
A new component will be
launched within NHSN that will specifically examine antimicrobial
use (AU) and antimicrobial resistance (AR) within healthcare
facilities: Antimicrobial Use and Resistance (AUR) Component. The
goal of the AUR Component is to provide a mechanism for
facilities to report and analyze antimicrobial use and/or
resistance as part of local or regional efforts to reduce
antimicrobial resistant infections through antimicrobial
stewardship efforts or interruption of transmission of resistant
pathogens at their facility. AU and AR functionalities currently
exist within NHSN but participation is limited to inpatient
healthcare facilities. Moving the AU and AR Modules to a separate
NHSN Component will allow all healthcare facility types, such as
outpatient dialysis facilities and long-term care facilities, to
take advantage of these tools for antimicrobial stewardship.
This new form will add
a total of 100 burden hours to the ICR.
|
57.200
|
Healthcare Personnel
Safety Component Annual Facility Survey
|
No change
|
No changes
|
N/A
|
57.203
|
Healthcare Personnel
Safety Monthly Reporting Plan
|
No change
|
New
response options were added to this form: ‘influenza
vaccination summary for the hospital’ and ‘influenza
vaccination summary for the inpatient rehabilitation facility
unit(s).’
Number
of respondents increased from 50 to 11,000.
Number of
responses per respondent decreased from 9 to 1.
|
These
response options were added to allow facilities to separate the
reporting of influenza vaccination summary data from the
hospital units versus the inpatient rehabilitation facility
units for CMS reporting purposes.
Due
to an increase in CMS required reporting of influenza
vaccination summary data, this form must be completed by all
acute care facilities, inpatient rehabilitation facilities, long
term acute care facilities, and ambulatory surgical centers
participating in CMS reporting programs. Therefore, the number
of respondents using this form has been increased to 11,000.
Recent
updates within NHSN have allowed the monthly reporting plan to
be auto-populated after one month has been entered. Therefore,
facilities are now only required to submit this form once per
year and NHSN will automatically complete the remaining months’
reporting plans.
These
changes result in a net increase of 842 burden hours for this
form.
|
57.204
|
Healthcare Worker
Demographic Data
|
No change
|
No changes
|
N/A
|
57.205
|
Exposure to Blood/Body
Fluids
|
No change
|
No changes
|
N/A
|
57.206
|
Healthcare Worker
Prophylaxis/Treatment
|
No change
|
No changes
|
N/A
|
57.207
|
Follow-Up Laboratory
Testing
|
No change
|
No changes
|
N/A
|
57.210
|
Healthcare Worker
Prophylaxis/Treatment-Influenza
|
No change
|
No changes
|
N/A
|
57.300
|
Hemovigilance Module
Annual Survey
|
No change
|
No changes
|
N/A
|
57.301
|
Hemovigilance Module
Monthly Reporting Plan
|
No change
|
No changes
|
N/A
|
57.303
|
Hemovigilance Module
Monthly Reporting Denominators
|
No change
|
No changes
|
N/A
|
57.304
|
Hemovigilance Adverse
Reaction
|
No change
|
No changes
|
N/A
|
57.305
|
Hemovigilance Incident
|
No change
|
Order
of the questions was revised on the form.
Number of
responses per respondent decreased from 12 to 10 per year.
|
The
order was changed to streamline the data collection
process for the facilities.
The
form now accommodates the addition of up to 20 incident
codes and locations per form. This change allows
facilities to now report all the incidents that were
associated with an adverse reaction on a single form
instead of completing a new form for every single incident.
This change reduces the burden on facilities because they will
no longer need to complete separate forms in these situations.
These
changes result in a net decrease of 167 burden hours for this
form.
|
57.400
|
Outpatient Procedure
Component—Annual Facility Survey
|
No change
|
No changes
|
N/A
|
57.401
|
Outpatient Procedure
Component - Monthly Reporting Plan
|
No change
|
No changes
|
N/A
|
57.402
|
Outpatient Procedure
Component Event
|
No change
|
No changes
|
N/A
|
57.403
|
Outpatient Procedure
Component - Monthly Denominators and Summary
|
No change
|
No changes
|
N/A
|
57.500
|
Outpatient Dialysis Center
Practices Survey
|
No change
|
Add
question for CMS End Stage Renal Disease (ESRD) Network number
and name.
Add
answer response for question #7.
Add
a question to assess influenza vaccination status.
Add
question to assess hepatitis B vaccination of home hemodialysis
patients.
Update
response options for question #38.
Revisions
of question and response wording.
Increase total
respondents from 6,000 to 6,500.
|
Adding
variable for ESRD patient advocacy network # and network name in
order to clearly identify the facility’s network.
Adding
“Patient Care Technician” as response option to
gather more detailed information regarding all potential parties
that could be involved in infection control practices within the
facility.
Adding
the question “19c. Of your center’s MAINTENANCE,
NON-TRANSIENT, in-center hemodialysis patients from question
17a, how many received the influenza vaccine for the
current/most recent flu season?”
Adding
the question, “20a. Of your center’s MAINTENANCE,
NON-TRANSIENT, home hemodialysis patients from question 17b, how
many received at least 3 doses of hepatitis B vaccine ever?”
in order to distinguish the number of home hemodialysis patients
that received the vaccine only.
Update
response categories to include “Yes-all,” “Yes-some,
No-None” because want to examine how many facilities are
using none, some, or all nine of the CDC-recommended Core
interventions.
After
internal and external review, many of the questions and response
options have been edited for clarification purposes.
Increased
number of facilities from 6,000 to 6,500 to accommodate the
growing number of dialysis facilities anticipated over the next
3 years.
These
changes result in a net increase of 875 burden hours for this
form.
|
57.501
|
Dialysis Monthly Reporting
Plan
|
No change
|
Add
new fields for prevention process measures and patient
vaccination.
Increase total
respondents from 6,000 to 6,500.
|
Adding
the following sections for facilities to begin reporting on: HD
Catheter Connection/Disconnection, HD Catheter Exit Site Care,
AV Fistula & Graft Cannulation/Decannulation, Dialysis
Station Routine Disinfection, and Injection Safety. Adding
“Influenza Vaccination – Dialysis Patients”
under the new “Patient Vaccination” field so that
facilities can begin tracking patient vaccination events.
Increased
number of facilities from 6,000 to 6,500 to accommodate the
growing number of dialysis facilities anticipated over the next
3 years.
These changes result in
a net increase of 500 burden hours for this form.
|
57.502
|
Dialysis Event
|
No change
|
Add
question “suspected source of positive blood culture.”
Rewording
of two form elements.
Revision
of susceptibility options for Cefepime.
Increase number of
annual respondents from 6,000 to 6,500.
|
The
question “Where was this positive blood culture
collected?” was added to determine how well facilities are
able to follow-up on positive blood culture results produced
outside their facility.
Based
on analysis, we observed that non-vascular accesses were
erroneously included in reporting. Therefore, we are rewording
the response to “Other vascular access device,” in
order to specify vascular access types only and improve data
quality. Users also erroneously reported non-vascular accesses.
Therefore, modifying answer option to “Other vascular
access device” in order to specify vascular access types
only and improve data quality.
Recently
CLSI has updated the susceptibility options for Cefepime to
replace Intermediate (I) with Susceptible-dose dependent (S-DD)
for three organisms: Escherichia coli, Enterobacter, and
Klebsiella. Therefore the susceptibility options for Cefepime
for those three organisms should be changed from S, I, R, N to
S, S-DD, R, N on all NHSN event forms.
Increased
number of facilities from 6,000 to 6,500 to accommodate the
growing number of dialysis facilities anticipated over the next
3 years.
These
changes result in a net increase of 52,000 burden hours for this
form.
|
57.503
|
Denominators for Dialysis
Event Surveillance
|
Denominator for Outpatient
Dialysis
|
Change
in form title.
Removal
of ‘maintenance’ from form.
Wording
added for clarification.
Increase number of
annual respondents from 6,000 to 6,500.
|
The
title of the form has been changed from “Denominators for
Outpatient Dialysis” to “Denominators for Dialysis
Event Surveillance” in order to clarify that this form is
specific to dialysis event surveillance only and not applicable
to other surveillance options that are available under the new
Dialysis component.
Changing
verbiage of “maintenance hemodialysis
patients”/”maintenance hemodialysis” to
“hemodialysis outpatients”/“hemodialysis”
to prevent the inadvertent exclusion of acute care hemodialysis
patients, thereby improving data quality.
Changing
verbiage of the column header from “Patients” to
“Outpatients” to clarify that inpatients being
treated at the same facility should be excluded. The text has
been modified to “Other vascular access device (e.g.,
catheter-graft hybrid, port)” for clarification and
consistency between all dialysis forms.
Increased
number of facilities from 6,000 to 6,500 to accommodate the
growing number of dialysis facilities anticipated over the next
3 years.
These changes result in
a net increase of 600 burden hours for this form.
|
57.504
|
Prevention Process
Measures Monthly Monitoring for Dialysis
|
No change
|
Add
new fields to capture new variables.
Increase number of
annual respondents from 600 to 1,500.
|
Added
five new process measures that can significantly play a role in
improving adherence to best practices, thereby reducing
infection. Each additional measure dovetails the CDC-recommended
audit tools and they are as follows:
Hemodialysis
Catheter Connection/Disconnection, Hemodialysis Catheter Exit
Site Care, Arteriovenous Fistula and Graft
Cannulation/Decannulation, Dialysis Station Routine Disinfection,
and Injection Safety.
Increased
number for facilities from 600 to 1,500 to accommodate the
growing number of dialysis facilities anticipated over the next
3 years.
These changes result in
a net increase of 5,400 total burden hours for this form.
|
57.505
|
Dialysis Patient Influenza
Vaccination
|
No change
|
Replace
‘Flu vaccination date’ with ‘Event date.’
Reword
question “Was vaccine administered.”
Answer
options for “Was vaccine administered” have been
modified.
Increase number of
annual respondents from 250 to 325.
|
Replacing
“Flu Vaccination Date” with “Event Date”
to be able to collect date information for patients vaccinated
outside of the facility and for patients that declined
vaccination.
This
question was consolidated from three independent questions into
one question for simplicity.
The
answer options have been modified in order to guide the user
through the paper form about what additional information will be
required based on their selection.
Increased
number of facilities from 250 to 325 to accommodate the growing
number of dialysis facilities anticipated over the next 3 years.
These changes result in
an increase of 938 total burden hours.
|
57.506
|
Dialysis Patient Influenza
Vaccination Denominator
|
No change
|
Increase number
of annual respondents from 250 to 325.
|
Increased
number of facilities from 250 to 325 to accommodate the growing
number of dialysis facilities anticipated over the next 3 years.
This
change results in an increase of 63 total burden hours for this
form.
|
57.600
|
State Health Department
Validation Record
|
No change
|
No changes
|
N/A
|